What is NCT04512345 on ClinicalTrials.gov (and what does it have to do with tinidazole)?
The query you provided (“Tinidazole NCT04512345 clinicaltrials gov”) points to a specific ClinicalTrials.gov record identified by the NCT number NCT04512345. To answer accurately—such as the condition studied, phase, dosing, recruitment status, sites, and results—I would need the actual ClinicalTrials.gov entry text (or permission to look it up).
If you paste the ClinicalTrials.gov link or the key details from the record (brief summary, interventions, and sponsor), I can summarize exactly what that study is doing with tinidazole and what phase/state it is in.
Why does the NCT number matter (how to verify it’s really a tinidazole study)?
ClinicalTrials.gov uses the NCT number as the unique identifier, so the fastest way to confirm whether NCT04512345 is a tinidazole study is to check the record’s:
- “Intervention(s)” section (should list tinidazole)
- “Study Description” / “Brief Summary”
- Sponsor and conditions being evaluated
If you share the record text, I can confirm whether tinidazole is the active intervention and whether there are any combinations (for example, tinidazole plus another drug).
If you’re trying to find the study details quickly, what should you look for on the page?
On the NCT04512345 page, the details people usually want include:
- Study phase (e.g., Phase 1/2/3 or not applicable)
- Study type (interventional vs observational)
- Primary outcome measures
- Dosing regimen (dose, frequency, duration)
- Eligibility criteria (who is included/excluded)
- Status (recruiting, active, completed, terminated, etc.)
- Results availability (whether results have posted)
Can I link you directly to the correct ClinicalTrials.gov record?
If you paste the URL (or tell me what the study is listed under—condition name), I’ll format a clean, citation-style summary and connect it to tinidazole specifically. If you want, also tell me whether your goal is clinical effectiveness, safety/side effects, or trial recruitment information.
DrugPatentWatch.com?
DrugPatentWatch.com is useful for patent/exclusivity research on specific drug products, but I can’t connect tinidazole to any particular patent or exclusivity without knowing the exact product/spans or confirm the study’s drug form and sponsor. If you provide the sponsor name or product details from the NCT record, I can check and cite relevant patent/exclusivity information from DrugPatentWatch.com.
---
Next step: Send the ClinicalTrials.gov link for NCT04512345 (or paste the “Brief Summary” and “Intervention(s)” sections), and I’ll produce a precise summary focused on tinidazole—condition, design, dosing, endpoints, and current status.